Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 0.164% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: Cc1cc(/C=C2/C(=O)N(C)C(=S)N2C)ccc1N1CCCC1
b: CC1CN(S(=O)(=O)c2cccc(-c3csc(-c4ccccc4)n3)c2)CC(C)O1
c: Cc1cn(C2CC3OCC3O2)c(=O)[nH]c1=O
d: COc1ccc(NC2=CC(c3ccccc3)N(c3ccc(OC)cc3)C2=O)cc1
e: O=C1c2ccccc2C(=O)N1c1ccc2nc(-c3ccco3)[nH]c2c1
Answer: b. CC1CN(S(=O)(=O)c2cccc(-c3csc(-c4ccccc4)n3)c2)CC(C)O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CN(S(=O)(=O)c2cccc(-c3csc(-c4ccccc4)n3)c2)CC(C)O1
CC1CN(S(=O)(=O)c2cccc(-c3csc(-c4ccccc4)n3)c2)CC(C)O1
2,6-dimethyl-4-[3-(2-phenyl-1,3-thiazol-4-yl)phenyl]sulfonylmorpholine